4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-016587
Chief Legal Officer sold 102,780 shares at $12.04 ($1,237,471)
- Chief Legal Officer acquired 138,632 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Barnes Alane P · Chief Legal Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-11 | Exercise or conversion : show line 1 in the form | +1,648 | $4.73 | $7,795 | 111,923 | D |
| 2021-05-11 | Exercise or conversion : show line 2 in the form | +33,132 | $1.42 | $47,047 | 145,055 | D |
| 2021-05-11 | Exercise or conversion : show line 3 in the form | +68,000 | $5.45 | $370,600 | 213,055 | D |
| 2021-05-11 | Sale : show line 4 in the form | −102,780 | $12.04 | $1,237,471 | 110,275 | D |
| 2021-05-12 | Exercise or conversion : show line 5 in the form | +35,852 | $4.73 | $169,580 | 146,127 | D |
| Open-market sales · 102,780 sh · avg $12.04 · $1,237,471 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-11 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −1,648 | 35,852 | D |
| 2021-05-11 | Exercise or conversion : show line 7 in the form Emp. Stock Option (Right to Buy) | −33,132 | 0 | D |
| 2021-05-11 | Exercise or conversion : show line 8 in the form Emp. Stock Option (Right to Buy) | −68,000 | 0 | D |
| 2021-05-12 | Exercise or conversion : show line 9 in the form Emp. Stock Option (Right to Buy) | −35,852 | 0 | D |
Loading xslF345X03/form4.xml…